Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Expert Review of Hematology|June 15, 2019
Considering the spleen in sickle cell diseaseSara El Hoss, Valentine BrousseBritish Journal of Haematology|November 21, 2024
From old to new: Repurposed drugs in the battle towards curing sickle cell diseaseSara El Hoss, Haoua BazoumCurrent Opinion in Hematology|February 25, 2021
Ineffective erythropoiesis in sickle cell disease: new insights and future implicationsWassim El Nemer, Auria Godard, Sara El HossHemasphere|August 24, 2022
Precision Medicine and Sickle Cell DiseaseSara El Hoss, Wassim El Nemer, David C ReesThe Biochemical Journal|July 15, 2015
Lopimune-induced mitochondrial toxicity is attenuated by increased uncoupling protein-2 level in treated mouse hepatocytesSara El Hoss, Georges M Bahr, Karim S EchtayHemasphere|January 23, 2026
Erythropoiesis in health and disease: Distinguishing defective and ineffective erythropoiesisSara El Hoss, Maria A Lizarralde-Iragorri, Thiago Trovati Maciel, et al.Haematologica|April 10, 2025
Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia modelDeborah E Daniels, Joeseph Hawksworth, Sara El Hoss, et al.Blood Reviews|March 16, 2024
Revolutionising healing: Gene Editing's breakthrough against sickle cell diseaseMarija Dimitrievska, Dravie Bansal, Marta Vitale, et al.American Journal of Hematology|August 30, 2023
Males with sickle cell disease have higher risks of cerebrovascular disease, increased inflammation, and a reduced response to hydroxyureaMargherita Di Mauro, Sara El Hoss, Amina Nardo-Marino, et al.American Journal of Hematology|July 8, 2022
The pleiotropic effects of α-thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co-transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survivalJohn N Brewin, Amina Nardo-Marino, Sara Stuart-Smith, et al.Pageof 3